moderna vaccine - Search News

News

Moderna, flu vaccine and mRNA

Moderna says its mRNA seasonal flu shot is 27% better than current vaccine

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a standard flu shot, the company announced this week.

U.S. News & World Report · 8h

Moderna’s New Flu Shot Shows Strong Results in Older Adults

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA. Copyright © 2025 HealthDay. All rights reserved.

The Wall Street Journal on MSN · 1d

Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

NBC New York1d

Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product ...

FDA expanding COVID vaccine warnings over rare heart side effect

The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...

Stock Movers: Circle Falls, Disney Climbs, Moderna Meets Flu Shot Goal

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results